Back to search

Article

PKC-alpha promotes phosphorylation of KRAS suppressing its oncogenic properties

2022-05-25

Abstract excerpt

Oncogenic KRAS-driven cancers have long been considered as “undruggable” due to limited therapeutic options. While the recent success of KRAS-G12C inhibitors argues against the “undruggability” of KRAS, this treatment only benefits a small proportion of patients with KRAS mutant cancers, leaving an urgent need for modalities to target other KRAS mutants. KRAS-calmodulin (CaM) signaling axis reportedly regulates th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a3f1a269-8e58-5cb7-8caf-1bb6fe3dd7e3
DOI
10.1101/2022.05.24.493257
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PKC-alpha promotes phosphorylation of KRAS suppressing its oncogenic propertiesDOI 10.1101/2022.05.24.493257
Select a neighboring publication to make it the new centre.